Your shopping cart is currently empty

SRC-3-IN-1 (compound SI-10) is an inhibitor of steroid receptor coactivator 3 (SRC-3) with an IC50 of 3.3 μM. It features good water solubility, oral bioavailability, and selectivity. SRC-3-IN-1 is applicable for prostate cancer research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | SRC-3-IN-1 (compound SI-10) is an inhibitor of steroid receptor coactivator 3 (SRC-3) with an IC50 of 3.3 μM. It features good water solubility, oral bioavailability, and selectivity. SRC-3-IN-1 is applicable for prostate cancer research. |
| In vitro | SRC-3-IN-1 demonstrates high potency against various cancer cell lines at different concentrations over 72 hours. Additionally, SRC-3-IN-1 exhibits significant selectivity for its intended target compared to non-targets, with effectiveness in the single-digit nanomolar range. |
| In vivo | SRC-3-IN-1 administered orally at doses of 50 and 100 mg/kg for 4 consecutive weeks does not lead to weight loss in mice. When given intraperitoneally at 10 mg/kg daily for 4 weeks, it extends mouse survival by inhibiting tumor angiogenesis. Additionally, a daily intraperitoneal dose of 10 mg/kg over 4 weeks reduces the tumor-to-femur area ratio by more than 50%. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.